Evidence map›Paper›PMID 21307398›Full record

ArticleOncotarget2010

The heme oxygenase-1 and c-FLIP in acute myeloid leukemias: two non-redundant but mutually exclusive cellular safeguards protecting cells against TNF-induced cell death?

S Shirley, O Micheau

Open access · hybridAbstract readComment
In one paragraph

Article in Oncotarget, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. High TCTA expression is an adverse prognostic biomarker in acute myeloid leukemia.Cancer biomarkers : section A of Disease markers · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

S ShirleyINSERM, U866, Dijon, F-21079 France; Faculty of Medicine and Pharmacy, Univ. Bourgogne, Dijon, F-21079, France.
O MicheauINSERM, U866, Dijon, F-21079 France; Faculty of Medicine and Pharmacy, Univ. Bourgogne, Dijon, F-21079, France.
Université de Bourgogne · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug Resistance, NeoplasmAntineoplastic AgentsApoptosisCASP8 and FADD-Like Apoptosis Regulating ProteinHeme Oxygenase-1HumansLeukemia, Myeloid, AcuteSignal TransductionTumor Necrosis Factor-alphaAntineoplastic AgentsCASP8 and FADD-Like Apoptosis Regulating ProteinHeme Oxygenase-1HMOX1 protein, humanTumor Necrosis Factor-alpha

Identifiers

PMID21307398
PMCPMC3157731
OpenAlexW2139667146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.